Bold
Investors
ASX
Latest News
ASX Announcements
Companies
Home
ASX Announcements
ATH Announcements
FDA Meeting Minutes Confirm…
ATH
ALTERITY THERAPEUTICS LIMITED
Market sensitive
FDA Meeting Minutes Confirm Registrational Path for ATH434
Date and time
7 July 2026 at 7:44 pm
Announcement type
Company Update
Show details
Hide details
Category
Other
Report codes
11001
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASX
Open original PDF
ATH announcement history
Recent ATH announcements
Disclosure Under Takeovers Panel GN 20
Application for quotation of securities - ATH
Granted New U.S. Composition of Matter Patent for ATH434
Application for quotation of securities - ATH
Alterity to Present at Canaccord Genuity Growth Conference
Application for quotation of securities - ATH